Blogs

Menopause care has moved well beyond “just put up with it”. In the UK, more people now expect tailored support for symptoms such as hot flushes, night sweats, sleep disruption, mood changes, brain fog, vaginal dryness and recurrent urinary tract symptoms. Spring 2026 is a useful time to reassess because routines change (lighter evenings, more activity, travel, social plans) and symptom patterns can shift with sleep, stress, alcohol intake and temperature swings.

Menopause Medications & Treatments for this season is the focus of this guide.

This article summarises the mainMenopause Medications & Treatments for this season-including hormone replacement therapy (HRT), non-hormonal prescription options, vaginal oestrogen, and evidence-informed non-prescription approaches. It explains mechanisms, typicalbenefits, key side effects and safety considerations, and what to ask your GP (or menopause specialist) to help match treatments to your medical history and preferences.

Important:This is general information, not personal medical advice. Menopause medications can interact with other drugs and may be unsuitable for some conditions. If you have heavy bleeding, bleeding after sex, bleeding more than 12 months after your last period, new breast changes, chest pain, sudden shortness of breath, one-sided leg swelling, or neurological symptoms, seek urgent medical assessment.

Spring 2026: why your menopause plan might need a refresh

Menopause symptoms are driven largely by fluctuating and then persistently lower oestrogen levels, with knock-on effects in the brain’s temperature regulation, sleep architecture, urogenital tissues, bone turnover and cardiovascular risk markers. Your needs can change over time because:

• Vasomotor symptoms(hot flushes/night sweats) often peak around the final menstrual period, then gradually ease for many-but can persist for years in others.
• Genitourinary syndrome of menopause (GSM)-vaginal dryness, burning, pain with sex, urinary urgency and recurrent infections-tends to worsen without treatment.
• Life factorssuch as stress, caring responsibilities, and sleep disruption can amplify symptoms.
• Health changes(blood pressure, migraines, weight, thyroid disease, new medications) can alter what’s safest.
• Preference changes: some people want to simplify routines, switch from tablets to patches/gel, or avoid sedation.

If you’d like to browse commonly used categories in one place, Elovita’smenopause medications and treatments collectioncan help you understand the range people often discuss with their GP, alongside non-prescription supportive options.

Hormone replacement therapy (HRT): what it is, who it can help, and the key choices

HRT replaces oestrogen (and usually progesterone/progestogen if you have a womb) to reduce symptoms caused by hormone withdrawal. Large bodies of evidence show HRT is the most effective treatment for vasomotor symptoms, and it is also effective for GSM. It can help sleep indirectly by reducing night sweats, and may improve quality of life for many.

In the UK, HRT is available in different formulations and routes:

• Transdermal oestrogen(patches, gel, spray): delivers oestrogen through the skin. Often preferred for people with migraine, higher VTE (blood clot) risk, raised BMI, or those who want steadier levels.
• Oral oestrogen(tablets): convenient for some, but can increase certain clotting factors because it passes through the liver first (first-pass metabolism).
• Progesterone/progestogen(capsules/tablets, or intrauterine system): protects the womb lining (endometrium) from overgrowth when oestrogen is used.
• Combined HRT(oestrogen + progestogen in one product): simpler regimen for many.

How HRT works (mechanisms in plain English)

Oestrogen interacts with receptors in the hypothalamus (a brain region involved in temperature regulation), which helps stabilise the narrowed “thermoneutral zone” that contributes to hot flushes. In vaginal and urinary tissues, oestrogen supports epithelial thickness, blood flow, elasticity and a healthier pH-factors linked with dryness, irritation and susceptibility to infections. In bone, oestrogen reduces bone resorption (breakdown) by influencing osteoclast activity, which helps slow loss of bone mineral density.

Expected benefits

• Most effective option forhot flushesandnight sweats.
• Often improvessleep qualityand daytime fatigue when night sweats ease.
• Helpsvaginal drynessand discomfort (especially when paired with local vaginal oestrogen if needed).
• Supportsbone healthwhile used (important if osteoporosis risk is a concern).

Side effects and safety considerations to know

Side effects vary by product and dose, and often settle after the first few months. Common issues include breast tenderness, bloating, nausea, headaches, and breakthrough bleeding (especially early on or when regimens change). The main safety considerations discussed in UK guidance relate to blood clots, stroke, and breast cancer risk-each influenced by age, time since menopause, route of oestrogen, type of progestogen, dose, and personal/family history.

General evidence trends (your clinician will personalise these):

• Route matters:transdermal oestrogen is generally associated with a lower risk of venous thromboembolism than oral oestrogen in observational data.
• Progestogen choice matters:different progestogens may have different risk profiles; micronised progesterone is often discussed as having a more favourable profile for some outcomes, but individual suitability varies.
• Timing matters:starting HRT before age 60 or within 10 years of menopause is often associated with a more favourable benefit-risk balance for many healthy individuals, though this is not a blanket rule.
• Bleeding needs review:persistent or new bleeding patterns should be assessed, particularly after a stable period on HRT.

For a broad view of the options people commonly consider, see Elovita’smenopause treatment optionshub (use it as a starting point for questions to take to your GP).

Key HRT choices to discuss with your GP

• Do you still have a womb?If yes, you’ll usually need progesterone/progestogen alongside oestrogen.
• Continuous vs sequential regimens:sequential HRT can cause regular withdrawal bleeds; continuous combined aims for no bleeding after the settling-in period.
• Patch/gel vs tablets:consider migraine, clot risk factors, convenience, skin sensitivity, and adherence.
• Dose and titration plan:start low and adjust based on symptom control and side effects, with a follow-up timeline.
• Target symptoms:vasomotor symptoms and GSM may need different strategies (systemic plus local treatment).

Local (vaginal) oestrogen and non-hormonal moisturisers: first-line for GSM symptoms

If your main issues are vaginal dryness, burning, painful sex, recurrent cystitis-like symptoms, or urinary urgency, local therapy is often central. GSM is common in peri-menopause and post-menopause, and it typically does not improve without targeted treatment.

Vaginal oestrogen: benefits and side effects

Vaginal oestrogen (tablets, creams, rings) delivers a small dose to local tissues. Evidence supports improvement in dryness, irritation and dyspareunia, and it can help some urinary symptoms. Systemic absorption is generally low, though it can vary by preparation and individual factors.

Possible side effects include local irritation or discharge, and-less commonly-spotting. If you have a history of oestrogen-sensitive cancer or are on certain cancer therapies, your GP may coordinate with your specialist to weigh options.

Non-hormonal options for daily comfort

Vaginal moisturisers (used regularly) and lubricants (used during sex) can reduce friction and discomfort. Look for products with physiologically compatible pH and osmolality where possible; some people find perfumed products irritating. Pelvic floor physiotherapy and gentle dilator therapy can also be useful where vaginismus or pelvic pain co-exists.

For an overview of supportive choices people often add alongside prescriptions, exploremenopause symptom support productsand discuss which are appropriate for you with a clinician, especially if you have allergies or recurrent irritation.

Non-hormonal prescription treatments for hot flushes: what to know in 2026

Not everyone can use HRT, and some simply prefer not to. Non-hormonal prescription options can reduce vasomotor symptoms, though average effect sizes are typically smaller than HRT. Choices may be influenced by mood symptoms, sleep issues, blood pressure, and medication interactions.

SSRIs and SNRIs (e.g., paroxetine, citalopram, escitalopram, venlafaxine)

These medications affect serotonin and/or noradrenaline pathways involved in thermoregulation. Trials show they can reduce hot flush frequency and severity for some people, and may be particularly relevant if anxiety or depression is also present.

Possible side effects:nausea, insomnia or sleepiness, sexual dysfunction, dry mouth, and (initially) jitteriness. They can interact with other medicines; for example, some SSRIs may not be suitable with specific breast cancer treatments due to enzyme interactions-your GP will check.

Gabapentin

Gabapentin is sometimes used off-label for hot flushes, with evidence of benefit in some studies. It may be considered when night sweats severely disrupt sleep.

Possible side effects:dizziness, drowsiness, and unsteadiness-important if you drive early in the morning, work at heights, or are at risk of falls.

Clonidine

Clonidine has been used for vasomotor symptoms, though benefits are modest for many and side effects can limit use.

Possible side effects:dry mouth, constipation, low blood pressure and dizziness.

Neurokinin-3 receptor antagonists (NK3R antagonists)

In recent years, a new class of non-hormonal treatments has been developed to target the neurokinin B pathway in the hypothalamus, which plays a role in hot flush generation. Clinical trials show meaningful reductions in vasomotor symptoms for some people, with ongoing monitoring for side effects and suitability. Availability and prescribing criteria can vary across the UK, and your GP may refer you to a specialist depending on local pathways.

If you’re reviewingMenopause Medicationsthis spring, it can help to compare practical considerations (daily tablet vs patch vs intermittent use, sedation risk, interaction checks). Elovita’smenopause relief collectionis a useful checklist-style overview to guide your questions-your GP remains the right person to advise on prescriptions.

Targeting specific symptoms: matching treatments to what bothers you most

Menopause isn’t one symptom-it’s a cluster. A targeted approach can reduce unnecessary medication changes and help you judge what’s working.

1) Hot flushes and night sweats

Most effective:systemic HRT (oestrogen with endometrial protection if needed).Alternatives:SSRIs/SNRIs, gabapentin, NK3R antagonists, lifestyle strategies (cool bedroom, breathable bedding, limiting alcohol, pacing spicy foods).

2) Low mood, anxiety and irritability

HRT can improve mood symptoms for some people, especially when symptoms are temporally linked with hormonal fluctuation in peri-menopause. If you have persistent depression or anxiety, evidence-based psychological therapies (e.g., CBT) and/or antidepressants may be appropriate. If sleep is disrupted by night sweats, treating vasomotor symptoms can indirectly improve mood and concentration.

3) Sleep disruption

First identify drivers: night sweats, restless legs, stress, alcohol, sleep apnoea, or pain. HRT can help when vasomotor symptoms wake you. For others, non-hormonal options and behavioural sleep strategies can be key. Be cautious with sedating medications if you’re groggy the next day.

4) Vaginal dryness, painful sex, urinary urgency or recurrent UTI symptoms

Local vaginal oestrogen plus moisturisers/lubricants is often central. Pelvic floor therapy, regular sexual activity (if comfortable), and avoiding irritants can help. If symptoms persist, ask your GP to consider other diagnoses too (e.g., infections, dermatological conditions such as lichen sclerosus, or pelvic floor dysfunction).

5) Bone health and fracture risk

HRT helps reduce bone loss while used, but it isn’t the only strategy. Calcium intake, vitamin D status, resistance training, and (when indicated) osteoporosis medications are part of the bigger picture. If you have risk factors (early menopause, family history of hip fracture, long-term steroid use), ask about a FRAX assessment and whether a DEXA scan is appropriate.

To explore supportive adjuncts that many people use alongside medical care-without replacing it-seeMenopause Medications & Treatmentsresources and bring your shortlist to your next appointment.

What to ask your GP in spring 2026: a practical checklist

Appointments can feel rushed, so it helps to arrive with specifics. Consider taking a 2-4 week symptom diary (flush frequency, sleep quality, bleeding, mood, triggers) and a list of current medications and supplements.

• Which symptoms are most likely menopause-relatedin my case, and which need separate investigation?
• Is HRT suitable for me?How do my age, migraine history, blood pressure, BMI, clot risk, smoking status, and family history affect the balance of benefits and risks?
• Which route is best-patch, gel, spray, or tablets-and why?
• If I have a womb, what’s the best endometrial protection?(e.g., micronised progesterone, combined preparations, intrauterine system)
• What side effects should I expectin the first 8-12 weeks, and what would be a red flag?
• How will we review success?What does “working” look like for my symptoms, and when should we adjust the dose?
• If I can’t or don’t want to use HRT, what are my non-hormonal options?Which fits best with my sleep, mood and other medications?
• Do I need local vaginal oestrogen?Can I use it alongside systemic HRT if dryness persists?
• What screening or monitoring do I need?(blood pressure, breast screening, bleeding review, risk assessments)

Evidence notes: what research can (and can’t) tell you

Menopause research includes randomised controlled trials, observational studies, and real-world safety data. Trials are strong for measuring symptom reduction over months, while longer-term risks (like blood clots or cancers) often rely on large observational datasets. This is why recommendations focus on personal risk factors, route and formulation, and regular review.

Also, menopause symptoms can overlap with thyroid disorders, iron deficiency, anxiety disorders, sleep apnoea and perimenopausal heavy bleeding. If something feels “different” or escalates quickly, it’s worth checking for other causes rather than assuming everything is menopause.

If you’re combining prescriptions with over-the-counter products, it’s wise to check ingredient lists and potential interactions-particularly with herbal products (for example, St John’s wort can interact with many medicines). A pharmacist can help alongside your GP.

FAQ: quick answers to common spring review questions

How long does it take for menopause treatments to start working?

It depends on the treatment and symptom. For hot flushes, many people notice improvement within a few weeks of starting systemic HRT, with fuller benefit often assessed around 8-12 weeks. Vaginal moisturisers can help comfort quickly, while vaginal oestrogen may take several weeks for tissue changes to build. Non-hormonal prescriptions can also take a few weeks; your GP will suggest when to review.

Can I use more than one approach at the same time?

Often, yes-because different symptoms respond to different therapies. For example, someone might use systemic HRT for hot flushes and sleep, plus local vaginal oestrogen or a moisturiser for GSM symptoms. Your GP or pharmacist should check for interactions if you also use antidepressants, migraine medicines, blood pressure tablets, or herbal supplements.

How to make your spring 2026 review feel easier

Bring a short symptom diary, be clear about your top two priorities (for example: “stop night sweats” and “reduce vaginal pain”), and ask for a specific follow-up plan. If you’re trying something new, request guidance on what’s normal early on, what would warrant stopping, and when to step up or switch.

To familiarise yourself with the range of commonly discussed options, you can browse Elovita’sMenopause Medications & Treatments collectionbefore your appointment and note what you’d like to ask about-then use your GP’s advice to decide what suits you now.

Sources and clinical context:This overview reflects widely cited evidence and UK clinical practice principles, including the role of systemic HRT for vasomotor symptoms, local oestrogen for GSM, and non-hormonal prescription options where HRT is unsuitable. Specific product choices, contraindications and monitoring should be confirmed with your GP, menopause specialist clinician, or pharmacist based on your personal medical history.